A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk
2005

Study on XRCC1 Gene Variants and Breast Cancer Risk

Sample size: 502 publication Evidence: moderate

Author Information

Author(s): Alpa V Patel, Eugenia E Calle, Alexandre L Pavluck, Heather Spencer Feigelson, Michael J Thun, Carmen Rodriguez

Primary Institution: American Cancer Society

Hypothesis

Does genetic variation in XRCC1 influence postmenopausal breast cancer risk?

Conclusion

Genetic variation in XRCC1, particularly the Arg194Trp polymorphism, may influence postmenopausal breast cancer risk, especially among smokers.

Supporting Evidence

  • Trp194 carriers had a 38% lower incidence of breast cancer compared to non-carriers.
  • The association was stronger among smokers, with an odds ratio of 2.76 for the Arg399Gln polymorphism.
  • The study included 502 breast cancer cases matched with 502 controls.

Takeaway

This study found that some changes in a gene related to DNA repair might make women more or less likely to get breast cancer, especially if they smoke.

Methodology

The study used a case-control design with 502 breast cancer cases and 502 matched controls, analyzing XRCC1 polymorphisms through genotyping.

Potential Biases

Potential for selection bias was minimized by prospective data collection.

Limitations

Limited statistical power to examine interactions due to small sample size and low smoking prevalence.

Participant Demographics

Participants were predominantly white women aged 50 to 74 years.

Statistical Information

P-Value

0.01

Confidence Interval

95% CI 0.40 to 0.95 for Trp194 carriers

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr1355

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication